| ¿µ¹® | exchange transfusion | ÇÑ±Û | ±³È¯¼öÇ÷ |
|---|---|---|---|
| ¼³¸í | ÇÑÂÊÀ¸·Î´Â ÇǸ¦ »Ì¾Æ³»¸é¼ ´Ù¸¥ ÂÊÀ¸·Î´Â °°Àº ¾çÀÇ ÇǸ¦ ³Ö¾î ¿Â¸öÀÇ ÇǸ¦ °¥¾Æ ³Ö´Â ¼öÇ÷¹æ¹ý. °«³¾ÆÀÌÀÇ ¿ëÇ÷º´ÀÇ Ä¡·á¹ýÀ¸·Î ¾´´Ù. |
||
| ¿µ¹® | transfusion | ÇÑ±Û | ¼öÇ÷ |
|---|---|---|---|
| ¼³¸í | °Ç°ÇÑ »ç¶÷¿¡°Ô¼ äÃëÇÑ Ç÷¾×À», Ç÷¾×À̳ª ±× ¼ººÐÀÌ ºÎÁ·ÇÑ È¯ÀÚÀÇ Ç÷°ü ³»¿¡ ÁÖÀÔÇÏ´Â Ä¡·á ¹æ¹ý. ¼öÇ÷Àº ºóÇ÷ ¶Ç´Â °¢Á¾ ´ë·® ½ÇÇ÷°ú ¼ö¼ú½Ã ÇÇÇÒ ¼ö ¾ø´Â ÃâÇ÷¿¡ ¹Ýµå½Ã ÇÊ¿äÇÑ ±¸¸íóġ·Î¼ ȯÀÚÀÇ Ç÷¾×Çü¿¡ ÀûÇÕÇÑ ¾çÁúÀÇ Ç÷¾×ÀÌ ¿ä±¸µÈ´Ù. ¼öÇ÷Àº º¸Åë ÀüÇ÷À» Á¤¸Æ ³»¿¡ ÁÖÀÔÇÏÁö¸¸, ¶§·Î´Â °ñ¼ö ³» ¶Ç´Â µ¿¸Æ ³»¿¡ ¼öÇ÷ÇÒ ¶§µµ ÀÖ´Ù. ¼öÇ÷ÇÏ´Â Ç÷¾×µµ ÀüÇ÷ÀÌ ¾Æ´Ñ ¾×»ó ¼ººÐÀÎ ³ÃÀå ¶Ç´Â ³Ãµ¿Ç÷ÀåÀ» »ç¿ëÇÒ ¼ö ÀÖ°í, ÀûÇ÷±¸³ª ¹éÇ÷±¸-Ç÷¼ÒÆÇ°ú °°Àº ¼¼Æ÷¼ººÐÀ» ¿ø½ÉºÐ¸®ÇÏ¿© ±ÍÁßÇÑ Ç÷¾×À» ´õ ¾Æ³¢°í ´õ È¿°úÀûÀ¸·Î ¾²°í ÀÖ´Ù. ¼öÇ÷ÀÇ È¿°ú´Â ¼øÈ¯Ç÷¾×·®À» º¸ÃæÇÏ¿© Ç÷¾ÐÀ» À¯ÁöÇϰí, ºÎÁ·ÇÑ °¢Á¾ Ç÷¾×¼ººÐÀ» °ø±Þ Á¶Á¤Çϸç, Á¶Ç÷±â´ÉÀ» ÀÚ±ØÇÏ´Â ÀÏ µîÀ» µé ¼ö ÀÖ´Ù. ±ä±ÞÇÑ ¼öÇ÷ÀÇ ´ë»óÀº ±³Åë»ç°í µî ¿Ü»ó¿¡ ÀÇÇÑ ´ëÃâÇ÷°ú À§±Ë¾ç-ÀڱÿÜÀӽŠµî¿¡ µû¸£´Â º´Àû ÃâÇ÷°ú °¢Á¾ Ç÷¾×Áúȯ¿¡ ¼ö¹ÝµÇ´Â ºóÇ÷°ú ¹éÇ÷±¸ ¹× Ç÷¼ÒÆÇ °¨¼Ò, ±×¸®°í Ç÷¿ìº´ ȯÀÚ³ª ´Ù¸¥ ȯÀÚ¿¡¼ º¼ ¼ö ÀÖ´Â Ç÷¾×ÀÀ°íÀÎÀÚ ºÎÁ·°ú È»óȯÀÚ-°£Áúȯ µî¿¡¼ ºÎÁ·ÇØÁø Ç÷Àå ¶Ç´Â ¾ËºÎ¹ÎÀÇ º¸Ãæ°ú ¸é¿ªÃ¼°¡ ºÎÁ·ÇÏ¿© °¨¿°ÁõÀÌ »ý±ä ȯÀÚ¿¡°Ô ºÎÁ·ÇÑ Ç×ü¸¦ Æ÷ÇÔÇÑ Ç÷¾× ¶Ç´Â Ç÷ÀåÁ¦Á¦¸¦ ÁÖ´Â °Íµµ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| ¿µ¹® | transfusion reaction | ÇÑ±Û | ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ |
|---|---|---|---|
| ¼³¸í | ¼öÇ÷ÇÏ¿´À» ¶§¿¡ ȯÀÚ¿¡°Ô ÀϾ´Â ¹ÝÀÀ. ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¿ëÇ÷ ¹ÝÀÀÀÌ ÀÖ´Ù. |
||
| CDI | cell-directed inhibitor; central or chronic diabetes insipidus; Children's Depression Inventory; col... |
|---|---|
| DAD | delayed afterdepolarization; diffuse alveolar damage; dispense as directed |
| DSUH | directed suggestion under hypnosis |
| MEDIHC | Military Experience Directed Into Health Careers |
| ODB | opiate-directed behavior |
| ADEPT | Antibody Directed Enzyme Prodrug Therapy |
|---|---|
| GDEPT | Gene directed enzyme prodrug therapy |
| PDPK | Proline-directed protein kinase |
| SDM | Site-directed mutagenesis |
| BT | Blood transfusion |
| Antibody Directed Enzyme Prodrug Therapy | <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately. The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects. Acronym: ADEPT (14 Nov 1997) |
|---|---|
| RNA-directed DNA polymerase | <enzyme> An enzyme that synthesises DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. Chemical name: Deoxynucleotide-triphosphate:DNA deoxynucleotidyltransferase (RNA-directed) Registry number: EC 2.7.7.49 (12 Dec 1998) |
| mutagenesis, site-directed | Mutagenesis where the mutation is caused by in vitro induction directed at a specific site in a DNA molecule. The most common method involves use of a chemically synthesised oligonucleotide mutant which can hybridise with the DNA target molecule. The resulting mismatch-carrying DNA duplex may then be transfected into a bacterial cell line and the mutant strands recovered. (12 Dec 1998) |
| site-directed mutagenesis | <molecular biology> Any of several methods used to create specific alterations in a gene. (09 Oct 1997) |
| directed molecular evolution | Techniques used to produce molecules exhibiting properties that conform to the demands of the experimenter. (12 Dec 1998) |
| DNA-directed DNA polymerase | <enzyme> DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. Chemical name: Deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) Registry number: EC 2.7.7.7 (12 Dec 1998) |
| DNA-directed RNA polymerase | <enzyme> A group of enzymes that catalyses DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesised. Chemical name: Nucleoside-triphosphate:RNA nucleotidyltransferase (DNA-directed) Registry number: EC 2.7.7.6 (12 Dec 1998) |
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
| arterial transfusion | Direct transfusion from an artery of the donor into an artery of the receptor. (05 Mar 2000) |
| blood component transfusion | The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in plasmapheresis and types of cytapheresis (plateletpheresis and leukapheresis) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor. (12 Dec 1998) |
| blood transfusion | The process of infusing blood products into a patient to raise the individuals concentration of red blood cells. Blood is typed (A, B, O or AB) and crossmatched (mixed together to see if its compatible) prior to transfusion. (27 Sep 1997) |
| blood transfusion, autologous | Reinfusion of blood or blood products derived from the patient's own circulation. (12 Dec 1998) |
| blood transfusion, intrauterine | Transfusion of rh-negative blood into the peritoneal cavity of an unborn infant in the treatment of foetal erythroblastosis (erythroblastosis, foetal) in utero. (12 Dec 1998) |
| blood transfusion reaction | This refers to an immune response against transfused blood cells. Antigens, on the surface of red blood cells, are recognised as foreign proteins and can stimulate sensitised lymphocytes to produce antibodies to the red blood cell antigens. This triggers a complex immunological reaction that results in the destruction of the transfused red blood cell. The blood groups (A, B, AB, O) are classified on the basis of the presence of surface antigens on the red blood cell. Type A blood has A antigens. The plasma component of the blood contains the antibodies against all other blood group antigens other that its own. Another type of surface antigen is known as Rh factor. Rh factor is either present (Rh positive) or absent (Rh negative). Rh compatibility is another requirement for blood transfusion. Symptoms and findings of a transfusion reaction include flank pain, fever, chills, bloody urine, rash, low blood pressure, dizziness and fainting. (27 Sep 1997) |
| reciprocal transfusion | An attempt to confer immunity by transfusing blood taken from a donor into a receiver suffering from the same affection, the balance being maintained by transfusing an equal amount from the receiver to the donor. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|